Bioharvest Sciences Inc (BHST)
BioHarvest Sciences Inc. is a common stock listed on NASDAQ under the symbol BHST. The company operates as a biotechnology business with activities in Israel, the United States, and Canada. Its operations are organized into Nutraceuticals and Pharmaceuticals segments, and it focuses on botanical synthesis platform technology designed to produce plant cells with elevated levels of active ingredients. BioHarvest Sciences is engaged in research, development, manufacturing, marketing, and sales of science-based health and wellness nutraceutical products, including dietary supplements and functional foods, along with cosmeceutical solutions. It also provides contract development and manufacturing services. Among its products is VINIA, a red grape cell dietary supplement containing polyphenols associated with red wine.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-BHST
|
$2.65
|
75.7% Upside
|
Bargain
|
$10.50
|
595.4% Upside
|
Bargain
|
Fair
|
0.0%
|
November 13, 2026
|
1.9x
|
1.0x
|
34.228 M
|
36.194 M
|
30.3%
|
85.2%
|
-3.1
|
97.1%
|
